Combination of sofosbuvir, pegylated-interferon and ribavirin for treatment of hepatitis C virus genotype 1 infection: a systematic review and meta-analysis

被引：0
|
作者：
Fardin Dolatimehr
Hamidreza Karimi-Sari
Mohammad Saeid Rezaee-Zavareh
Seyed Moayed Alavian
Bita Behnava
Mohammad Gholami-Fesharaki
Heidar Sharafi
机构：
[1] Student Research Committee,Baqiyatallah Research Center for Gastroenterology and Liver Diseases (BRCGL)
[2] Baqiyatallah University of Medical Sciences,Department of Biostatistics, Faculty of Medical Sciences
[3] Meta-analysis Study Group,undefined
[4] Iran Hepatitis Network,undefined
[5] Baqiyatallah University of Medical Sciences,undefined
[6] Middle East Liver Disease (MELD) Center,undefined
[7] Tarbiat Modares University,undefined
来源：
DARU Journal of Pharmaceutical Sciences | / 25卷
关键词：
Hepatitis C; Sofosbuvir; Ribavirin; Pegylated-interferon; Meta-analysis;
D O I：
暂无
中图分类号：
学科分类号：
摘要：
引用
收藏
相关论文
共 50 条
  • [31] TYPE II MIXED CRYOGLOBULINEMIA IN PATIENTS WITH HEPATITIS C VIRUS: TREATMENT WITH PEGYLATED-INTERFERON AND RIBAVIRIN
    Malaguarnera, Michele
    Scuderi, Laura
    Ardiri, Annalisa
    Malaguarnera, Giulia
    Bertino, Nicoletta
    Ruggeri, Irene Maria
    Greco, Carmela
    Ozyalcn, Erdogan
    Bertino, Emanuele
    Bertino, Gaetano
    ACTA MEDICA MEDITERRANEA, 2015, 31 (03): : 651 - 662
  • [32] Retreatment of Patients With Chronic Hepatitis C Genotype 4 (HCV-4) Infection With Pegylated Interferon and Ribavirin (P/R): A Systematic Review and Meta-Analysis
    Zhang, Bing
    Yee, Brittany
    Nguyen, Nghia
    Yip, Benjamin
    Ayoub, Walid
    Nguyen, Mindie
    Lutchman, Glen
    AMERICAN JOURNAL OF GASTROENTEROLOGY, 2014, 109 : S185 - S185
  • [33] Safety and efficacy of sofosbuvir plus velpatasvir with or without ribavirin for chronic hepatitis C virus infection: A systematic review and meta-analysis
    Ahmed, Hussien
    Abushouk, Abdelrahman I.
    Attia, Attia
    Gadelkarim, Mohamed
    Gabr, Mohamed
    Negida, Ahmed
    Abdel-Daim, Mohamed M.
    JOURNAL OF INFECTION AND PUBLIC HEALTH, 2018, 11 (02) : 156 - 164
  • [34] Sustained virologic response to standard interferon or pegylated interferon and ribavirin in patients with hepatitis C virus genotype 5: systematic review and meta-analysis of ten studies and 423 patients
    Devaki, Pardha
    Jencks, David
    Yee, Brittany E.
    Nguyen, Mindie H.
    HEPATOLOGY INTERNATIONAL, 2015, 9 (03) : 431 - 437
  • [35] Sustained virologic response to standard interferon or pegylated interferon and ribavirin in patients with hepatitis C virus genotype 5: systematic review and meta-analysis of ten studies and 423 patients
    Pardha Devaki
    David Jencks
    Brittany E. Yee
    Mindie H. Nguyen
    Hepatology International, 2015, 9 : 431 - 437
  • [36] African-Americans with genotype-1 with chronic hepatitis C respond poorly to pegylated-interferon and ribavirin combination treatment as compared to Caucasians
    Khan, AA
    Mutchnick, MG
    Ehrinpreis, MN
    Dhar, R
    Siddiqui, FA
    AMERICAN JOURNAL OF GASTROENTEROLOGY, 2005, 100 (09): : S126 - S126
  • [37] Merimepodib, Pegylated Interferon, and Ribavirin in Genotype 1 Chronic Hepatitis C Pegylated Interferon and Ribavirin Nonresponders
    Rustgi, Vinod K.
    Lee, William M.
    Lawitz, Eric
    Gordon, Stuart C.
    Afdhal, Nezam
    Poordad, Fred
    Bonkovsky, Herbert L.
    Bengtsson, Leif
    Chandorkar, Gurudatt
    Harding, Matthew
    McNair, Lindsay
    Aalyson, Molly
    Alam, John
    Kauffman, Robert
    Gharakhanian, Shahin
    McHutchison, John G.
    HEPATOLOGY, 2009, 50 (06) : 1719 - 1726
  • [38] Hepatitis C Virus Genotype 1: How Genetic Variability of the Core Protein Affects the Response to Pegylated-Interferon and Ribavirin Therapy
    Alhamlan, F. S.
    Al-Ahdal, M. N.
    Khalaf, N. Z.
    Abdo, A. A.
    Sanai, F. M.
    Al-Ashgar, H. I.
    ElHefnawi, M.
    Zaid, A.
    Al-Qahtani, A. A.
    JOURNAL OF MEDICAL VIROLOGY, 2014, 86 (02) : 224 - 234
  • [39] Treatment of hepatitis C virus genotype 2 and 3 with pegylated interferon plus ribavirin
    Rizzetto, M
    JOURNAL OF HEPATOLOGY, 2005, 42 (02) : 275 - 276
  • [40] Effectiveness of Extending Treatment Duration in Therapy with Pegylated Interferon and Ribavirin for Genotype 2 Hepatitis C Virus Infection
    Nanba, Shintarou
    Ikeda, Fusao
    Fujioka, Shin-ichi
    Araki, Yasuyuki
    Takaguchi, Kouichi
    Hashimoto, Noriaki
    Seki, Hiroyuki
    Takaki, Akinobu
    Iwasaki, Yoshiaki
    Yamamoto, Kazuhide
    ACTA MEDICA OKAYAMA, 2015, 69 (04) : 237 - 244
12345